Based on public multi-omics analysis, GALNT2 was strongly elevated in ccRCC versus adjoining nontumor tissues, and it displayed a relationship with poor overall survival (OS) of ccRCC patients. This evidence concerns the gene GALNT2 and nonpapillary renal cell carcinoma.